TY - JOUR AU - Mathurin, P. AU - Bataller, R. PY - 2015 DA - 2015// TI - Trends in the management and burden of alcoholic liver disease JO - J Hepatol. VL - 62 UR - https://doi.org/10.1016/j.jhep.2015.03.006 DO - 10.1016/j.jhep.2015.03.006 ID - Mathurin2015 ER - TY - JOUR AU - Williams, R. AU - Horton, R. PY - 2013 DA - 2013// TI - Liver disease in the UK: a Lancet Commission JO - Lancet. VL - 382 UR - https://doi.org/10.1016/S0140-6736(13)62152-2 DO - 10.1016/S0140-6736(13)62152-2 ID - Williams2013 ER - TY - JOUR AU - Shah, V. H. PY - 2010 DA - 2010// TI - Alcoholic liver disease: the buzz may be gone, but the hangover remains JO - Hepatology. VL - 51 UR - https://doi.org/10.1002/hep.23686 DO - 10.1002/hep.23686 ID - Shah2010 ER - TY - JOUR AU - Hartmann, P. AU - Seebauer, C. T. AU - Schnabl, B. PY - 2015 DA - 2015// TI - Alcoholic liver disease: the gut microbiome and liver cross talk JO - Alcohol Clin Exp Res. VL - 39 UR - https://doi.org/10.1111/acer.12704 DO - 10.1111/acer.12704 ID - Hartmann2015 ER - TY - JOUR AU - Seki, E. AU - De Minicis, S. AU - Osterreicher, C. H. AU - Kluwe, J. AU - Osawa, Y. AU - Brenner, D. A. PY - 2007 DA - 2007// TI - TLR4 enhances TGF-beta signaling and hepatic fibrosis JO - Nat Med. VL - 13 UR - https://doi.org/10.1038/nm1663 DO - 10.1038/nm1663 ID - Seki2007 ER - TY - JOUR AU - Szabo, G. PY - 2015 DA - 2015// TI - Gut-liver axis in alcoholic liver disease JO - Gastroenterology. VL - 148 UR - https://doi.org/10.1053/j.gastro.2014.10.042 DO - 10.1053/j.gastro.2014.10.042 ID - Szabo2015 ER - TY - JOUR AU - Madsen, B. S. AU - Havelund, T. AU - Krag, A. PY - 2013 DA - 2013// TI - Targeting the gut-liver axis in cirrhosis: antibiotics and non-selective beta-blockers JO - Adv Ther. VL - 30 UR - https://doi.org/10.1007/s12325-013-0044-1 DO - 10.1007/s12325-013-0044-1 ID - Madsen2013 ER - TY - JOUR AU - Bass, N. M. AU - Mullen, K. D. AU - Sanyal, A. AU - Poordad, F. AU - Neff, G. AU - Leevy, C. B. PY - 2010 DA - 2010// TI - Rifaximin treatment in hepatic encephalopathy JO - N Engl J Med. VL - 362 UR - https://doi.org/10.1056/NEJMoa0907893 DO - 10.1056/NEJMoa0907893 ID - Bass2010 ER - TY - JOUR AU - DuPont, H. L. PY - 2016 DA - 2016// TI - Review article: the antimicrobial effects of rifaximin on the gut microbiota JO - Aliment Pharmacol Ther. VL - 43 UR - https://doi.org/10.1111/apt.13434 DO - 10.1111/apt.13434 ID - DuPont2016 ER - TY - JOUR AU - Kimer, N. AU - Pedersen, J. S. AU - Tavenier, J. AU - Christensen, J. E. AU - Busk, T. M. AU - Hobolth, L. PY - 2018 DA - 2018// TI - Rifaximin has minor effects on bacterial composition, inflammation and bacterial translocation in cirrhosis: a randomized trial JO - J Gastroenterol Hepatol. VL - 33 UR - https://doi.org/10.1111/jgh.13852 DO - 10.1111/jgh.13852 ID - Kimer2018 ER - TY - JOUR AU - Bajaj, J. S. AU - Heuman, D. M. AU - Sanyal, A. J. AU - Hylemon, P. B. AU - Sterling, R. K. AU - Stravitz, R. T. PY - 2013 DA - 2013// TI - Modulation of the metabiome by rifaximin in patients with cirrhosis and minimal hepatic encephalopathy JO - PLoS One. VL - 8 UR - https://doi.org/10.1371/journal.pone.0060042 DO - 10.1371/journal.pone.0060042 ID - Bajaj2013 ER - TY - JOUR AU - Adachi, Y. AU - Moore, L. E. AU - Bradford, B. U. AU - Gao, W. AU - Thurman, R. G. PY - 1995 DA - 1995// TI - Antibiotics prevent liver injury in rats following long-term exposure to ethanol JO - Gastroenterology. VL - 108 UR - https://doi.org/10.1016/0016-5085(95)90027-6 DO - 10.1016/0016-5085(95)90027-6 ID - Adachi1995 ER - TY - JOUR AU - Zhu, Q. AU - Zou, L. AU - Jagavelu, K. AU - Simonetto, D. A. AU - Huebert, R. C. AU - Jiang, Z. D. PY - 2012 DA - 2012// TI - Intestinal decontamination inhibits TLR4 dependent fibronectin-mediated cross-talk between stellate cells and endothelial cells in liver fibrosis in mice JO - J Hepatol. VL - 56 UR - https://doi.org/10.1016/j.jhep.2011.11.013 DO - 10.1016/j.jhep.2011.11.013 ID - Zhu2012 ER - TY - JOUR AU - Descombe, J. J. AU - Dubourg, D. AU - Picard, M. AU - Palazzini, E. PY - 1994 DA - 1994// TI - Pharmacokinetic study of rifaximin after oral administration in healthy volunteers JO - Int J Clin Pharmacol Res. VL - 14 ID - Descombe1994 ER - TY - JOUR AU - Costea, P. I. AU - Zeller, G. AU - Sunagawa, S. AU - Pelletier, E. AU - Alberti, A. AU - Levenez, F. PY - 2017 DA - 2017// TI - Towards standards for human fecal sample processing in metagenomic studies JO - Nat Biotechnol. VL - 35 ID - Costea2017 ER - TY - JOUR AU - Kozich, J. J. AU - Westcott, S. L. AU - Baxter, N. T. AU - Highlander, S. K. AU - Schloss, P. D. PY - 2013 DA - 2013// TI - Development of a dual-index sequencing strategy and curation pipeline for analyzing amplicon sequence data on the MiSeq Illumina sequencing platform JO - Appl Environ Microbiol. VL - 79 UR - https://doi.org/10.1128/AEM.01043-13 DO - 10.1128/AEM.01043-13 ID - Kozich2013 ER - TY - JOUR AU - Lieber, C. S. AU - Weiss, D. G. AU - Groszmann, R. AU - Paronetto, F. AU - Schenker, S. PY - 2003 DA - 2003// TI - Veterans Affairs Cooperative Study Group. II. Veterans Affairs Cooperative Study of polyenylphosphatidylcholine in alcoholic liver disease JO - Alcohol Clin Exp Res. VL - 27 UR - https://doi.org/10.1097/01.ALC.0000093743.03049.80 DO - 10.1097/01.ALC.0000093743.03049.80 ID - Lieber2003 ER - TY - JOUR AU - Gerard, L. AU - Garey, K. W. AU - DuPont, H. L. PY - 2005 DA - 2005// TI - Rifaximin: a nonabsorbable rifamycin antibiotic for use in nonsystemic gastrointestinal infections JO - Expert Rev Anti-Infect Ther. VL - 3 UR - https://doi.org/10.1586/14787210.3.2.201 DO - 10.1586/14787210.3.2.201 ID - Gerard2005 ER - TY - JOUR AU - West, J. AU - Card, T. R. PY - 2010 DA - 2010// TI - Reduced mortality rates following elective percutaneous liver biopsies JO - Gastroenterology. VL - 139 UR - https://doi.org/10.1053/j.gastro.2010.06.015 DO - 10.1053/j.gastro.2010.06.015 ID - West2010 ER - TY - JOUR AU - Lieber, C. S. AU - Weiss, D. G. AU - Groszmann, R. AU - Paronetto, F. AU - Schenker, S. PY - 2003 DA - 2003// TI - Veterans Affairs Cooperative Study Group. I. Veterans Affairs Cooperative Study of polyenylphosphatidylcholine in alcoholic liver disease: effects on drinking behavior by nurse/physician teams JO - Alcohol Clin Exp Res. VL - 27 UR - https://doi.org/10.1097/01.ALC.0000093744.12232.34 DO - 10.1097/01.ALC.0000093744.12232.34 ID - Lieber2003 ER -